Oral albuterol dosing during the latter stages of a resistance exercise program

Journal of Strength and Conditioning Research

Volumn 19, Issue 1, 2005, Pages 102-107

  Caruso, John F ^a   Hamill, John L ^a   De Garmo, Nicole ^a  

^a Healthcare Research Associates Inc   (United States)

Author keywords

Hypertrophic factors; Neural factors; Salbutamol; Strength training

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ELBOW; EXERCISE; HUMAN; KNEE; LEAN BODY WEIGHT; MALE; NORMAL HUMAN; SIDE EFFECT; TRAINING; VELOCITY;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; BODY COMPOSITION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; MUSCLE, SKELETAL; PHYSICAL EDUCATION AND TRAINING; WEIGHT LIFTING;

EID: 15744363503     PISSN: 10648011     EISSN: None     Source Type: Journal    
DOI: 10.1519/R-14793.1     Document Type: Article

References (40)

1. BROOKE, M.H., AND W.K. ENGLE. The histographic analysis of human muscle biopsies with regard to fiber types. Neurology 19:221-233. 1969.
2. BROOKE, M.H., AND K.K. KAISER. Muscle fiber types: How many and what kind? Arch. Neurol. 23:369-379. 1970.
3. CAIRNS, S.P., AND A.F. DULHUNTY. Beta-adrenergic potentiation of excitation-contraction coupling increases force in rat skeletal muscle. Muscle Nerve 16:1317-1325. 1993.
4. CARUSO, J.F., J.F. SIGNORILE, A.C. PERRY, B. LEBLANC, M. CLARK, AND M.M. BAMMAN. The effects of albuterol and isokinetic exercise on the quadriceps muscle group. Med. Sci. Sports Exerc. 27:1471-1476. 1995.
5. 2- adrenoreceptor activation. Am. J. Physiol. 263:E50-E56. 1992.
6. 2-adrenergic agonist (clenbuterol). J. Clin. Invest. 95:2367-2372. 1995.
7. DEITRICK, J.E., G.D. WHEDON, AND E. SHORR. Effects of immobilization upon various metabolic and physiological functions of normal men. Am. J. Med. 4:3-36. 1948.
8. DE VRIES, H.A. Efficiency of electrical activity as a measure of the functional state of muscle tissue. Amer. J. Phys. Med. 47: 10-22. 1968.
9. HINKLE, R.T., K.M.B. HODGE, D.B. CODY, R.J. SHELDON, B.K. KOBILKA, AND R.J. ISFORT. Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the β2-adrenergic receptor. Muscle Nerve 25:729-734. 2002.
10. IKAI, M., AND T. FUKUNAGA. A study on training effect on strength per unit cross-sectional area of muscle by means of ultrasonic measurement. Int. Z. Angew. Physiol. 28:173-180. 1970.
11. JENNEKENS, F.G.I., B.E. TOMLINSON, AND J.N. WALTON. Data on fibre types in five human limb muscles: An autopsy study. J. Neurol. Sci. 14:245-257. 1973.
12. JOHNSON, M.A., J. POLGAR, D. WEIGHTMAN, AND D. APPLETON. Data on the distribution of fibre types in thirty-six human muscles an autopsy study. J. Neurol. Sci. 18:111-129. 1973.
13. KEPPEL, G., W.H. SAULFEY, AND H. TOKUNAGA. Introduction to Design and Analysis. New York: W.H. Freeman and Company, 1992.
14. KIM, Y.S., AND R.D. SAINZ. Minireview of β-adrenergic agonists and hypertrophy of skeletal muscles. Life Sci. 50:397-407. 1992.
15. KINALI, M., E. MERCURI, M. MAIN, F. DE BIASIA, A. KARATAZA, R. HIGGINS, L.M. BANKS, A.Y. MANZUR, AND F. MUNTONI. Pilot trial of albuterol in spinal muscular atrophy. Neurology 59: 609-610. 2002.
16. KISSEL, J.T., M.P. MCDERMOTT, J.R. MENDELL, W.M. KING, S. PANDYA, R.C. GRIGGS, AND R. TAWIL. Randomized, double-blind, placebo-controlled trial of albuterol on facioscapulohumeral dystrophy. Neurology 57:1434-1440. 2001.
17. KRAEMER, W.J., S.J. FLECK, AND W.J. EVANS. Strength and power training: Physiological mechanisms of adaptation. In: Exercise Sport Science Review. J.O. Holloszy, ed., Baltimore: Williams and Wilkins, 1996. pp. 363-397.
18. 2-agonist administration and exercise on contractile elevation of skeletal muscle fibers. J. Appl. Physiol. 81:1610-1618. 1996.
19. LYNCH, G.S., AND D.A. WILLIAMS. The effect of exercise on the contractile properties of single skinned fast- and slow-twitch skeletal muscle fibers from the adult rat. Acta. Physiol. Scand. 150:141-150. 1994.
20. MALTIN, C.A., M.I. DELDAY, J.S. WATSON, S.D. HEYS, I.M. NEVISON, I.K. RITCHIE, AND P.H. GIBSON. Clenbuterol, a β-adrenergic agonist, increases relative muscle strength in orthopedic patients. Clin. Sci. 84:651-654. 1993.
21. MARTIN, W.H., A.R. COGGAN, R.J. SPINA, AND J.E. SAFFITZ. Effects of fiber type training and a β-adrenoreceptor density in human skeletal muscle. Am. J. Physiol. 257:E736-E742. 1989.
22. MARTIN, W.H., S.S. MURPHEE, AND J.E. SAFFITZ. β-adrenergic receptor distribution among muscle fiber types and resistance arterioles of white, red, and intermediate skeletal muscle. Circ. Res. 64:1096-1105. 1989.
23. 2 agonist, increases skeletal muscle strength in young men. Clin. Sci. 83:615-621. 1992.
24. MARTINEZ, J.A., M. RODRIGUEZ-MARASCAL, A.S. DEL BARRIO, AND J. LARRALDE. Changes in serum and urinary amino acids after a mixed β-adrenergic agonist. Ann. Nutr. Metab. 36:328-335. 1992.
25. 2-adrenoreceptor agonist salmeterol are dependent on route of administration. Am. J. Physiol. 267(Eridocrinol. Metab. 30):E475-E484. 1994.
26. MORITANI, T. Time course adaptation during strength and power training. In: Strength and Power in Sports. The Encyclopedia of Sports Medicine. P. Komi, ed. Oxford, England: Blackwell, 1992. pp. 266-278.
27. MORITANI, T., AND H.A. DE VRIES. Neural factors versus hypertrophy in the time course of muscle strength gain. Am. J. Phys. Med. 58:115-130. 1979.
28. MORITANI, T., AND H.A. DE VRIES. Potential for gross muscle hypertrophy in older men. J. Gerontol 35:672-682. 1980.
29. Physician's Desk Reference. (58th ed.) 2004. pp. 2375-2377.
30. PLOUTZ, L.L., P.A. TESCH, R.L. BIRO, AND G.A. DUDLEY. Effect of resistance training on muscle use during exercise. J. Appl. Physiol. 76:1675-1681. 1994.
31. REEDS, P.J., S.M. HAY, P.M. DORWOOD, AND R.M. PALMER. Stimulation of muscle growth by clenbuterol: Lack of effect on muscle protein biosynthesis. Br. J. Nutrit. 56:249-258. 1986.
32. 2-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat. Am. J. Physiol. Cell Physiol. 278:C582-C588. 2000.
33. RODRIGUEZ-MARISCAL, M., A.S. DEL BARRIO, J. LARRALDE, AND J.A. MARTINEZ. Free intracellular and protein-bound amino acids in tissues as affected by a mixed β-adrenergic agonist. Experimentia 49:308-312. 1993.
34. SALE, D.G. Neural adaptations to resistance training. Med. Sci. Sports Exerc. 20:S135-S145. 1988.
35. SALE, D.G. Neural adaptation to strength training. In: Strength and Power in Sports. The Encyclopedia of Sports Medicine. P. Komi, ed. Oxford, England: Blackwell, 1992. pp. 249-265.
36. STARON, R.S., D.L. KARAPONDO, W.J. KRAEMER, A.C. FRY, S.E. GORDON, J.E. FALKEL, F.C. HAGERMAN, AND R.S. HIKIDA. Skeletal muscle adaptations during the early phase of heavy-resistance training in men and women. J. Appl. Physiol. 76:1247-1255. 1994.
37. TURNBULL, L., J.F. HOH, R.I. LUDOWYKE, AND G.H. ROSSMANITH. Troponin I phosphorylation enhances crossbridge kinetics during beta-adrenergic stimulation in rat cardiac tissue. J. Physiol. 542:911-920. 2002.
38. WILLIAMS, R.S., M.G. CARON, AND K. DAMEL. Skeletal muscle β-adrenergic receptors: variations due to fiber type and training. Am. J. Physiol. 246:E160-E167. 1984.
39. 2 receptor agonist. Am. J. Physiol. 254(17):E726-E732. 1988.
40. 2-agonist, retards atrophy in denervated muscle. Am. J. Physiol. 252:E152-E155. 1987.